title: Scrutiny of Diane-35 due to potential dangers of off-label prescribing.
authors: Roger
authors: R
authors: Collier
mesh_terms: D002170:Canada; D017373:Cyproterone Acetate / Q000009:adverse effects* / Q000494:pharmacology; D004338:Drug Combinations; D004348:Drug Labeling; D011307:Drug Prescriptions; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D004997:Ethinyl Estradiol / Q000009:adverse effects* / Q000494:pharmacology; D005260:Female; D006801:Humans; D056687:Off-Label Use; D056737:Safety-Based Drug Withdrawals / Q000331:legislation & jurisprudence*
chemical_list: D004338:Drug Combinations; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; C032640:Cyproterone acetate, ethinyl estradiol drug combination